Emerging nanomedicine for liver diseases treatment
Yawen Zhu, Dongxue Ge, Jinglin Wang, Hao Sun, Wei Li, Haozhen Ren · 2025
Read Emerging nanomedicine for liver diseases treatment by Yawen Zhu, Dongxue Ge, Jinglin Wang, Hao Sun, Wei Li, Haozhen Ren (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12729200.txt.
Description
Yawen Zhu leads a team that reviews tiny drug carriers for liver disease. Their review from twenty twenty-five deals with nanomedicine for the liver. Liver ills have grown to a world wide burden.
Old cures for scar, fatty liver, and liver cancer work poorly. They can also bring harsh side effects for patients. Tiny carriers can aim drugs well and suit the body. Forms range from fat bubbles to cell shed vesicles. The team also flags gaps in safety, scale, and cost. Tailored cures for each person are a key need.
Catalog record
| CREATOR | Yawen Zhu, Dongxue Ge, Jinglin Wang, Hao Sun, Wei Li, Haozhen Ren |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 91 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |